TUCSON, Ariz.– HTG Molecular Diagnostics, Inc., a provider of instruments and reagents for molecular profiling applications, today announced the pricing of its initial public offering of 3,570,000 shares of its common stock at an initial public offering price of $14.00 per share. All of the shares of common stock are being offered by HTG. The […]
SEATTLE — The Cancer Immunotherapy Trials Network (CITN) and NanoString Technologies, Inc.(Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a multi-year translational research collaboration to discover biomarkers that predict clinical outcomes for cancer immunotherapies, both as single agents and in combination. The collaboration will involve the systematic […]
Pleasanton, CA – Unchained Labs, a refreshingly new biologic tools company, extends its coming out to this year’s PEGS conference and launches the UNit — the first and only multiplex protein stability system for biologics. PEGS: The Essential Protein Engineering Summit takes place in Boston, May 4-8, 2015. The UNit lets drug discovery researchers look […]
HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, appointed James Green as a Class I director of the Board of Directors to fill the new vacancy created by Dr. Robert Dishman’s retirement from the Board. Dr. Dishman served […]
Pleasanton, CA – Unchained Labs, a refreshingly new biologic tools company, announces its executive team is a wrap, uncaging the two latest members. The final two include Scott Lockard, VP Product Development, who jumps at the chance to harness cool new technologies to tackle real-world scientific problems. He’s led engineering, development and operations teams at […]
The Innovation Village, the GE Healthcare’s first in the UK, has created substantial interest amongst early stage life sciences businesses internationally – with more than 50 expressions of interest received to date since it was announced last month at BioWales 2015 – the flagship event for life sciences in Wales. Based within GE Healthcare’s existing […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced a strategic collaboration with the National University of Singapore (NUS) Yong Loo Lin School of Medicine in a move aimed to help researchers develop more effective medicine to treat cardiovascular disease. The Department of Medicine at the Yong Loo Lin School of Medicine at […]
SEATTLE — NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the expansion of its rapidly growing product portfolio focused on cutting edge genomic—and now proteomic—cancer research with the introduction of three new products for the nCounter® Analysis System. These products include the Immuno-Oncology RNA:Protein […]
Darmstadt, Germany — Merck, a leading company for innovative and top- quality high-tech products in healthcare, life science and performance materials, today announced that Udit Batra, currently CEO and President of Merck Millipore, has been appointed to lead the combined life science business of Merck Millipore and Sigma- Aldrich once the acquisition of Sigma-Aldrich has […]
Alameda, Calif. –– Singulex, Inc., the developer and leading provider of Single Molecule Counting technology for clinical diagnostics and scientific discovery, today announced a collaboration agreement with CHDI Foundation, a nonprofit biomedical research organization exclusively dedicated to rapidly developing drugs that will slow the progression of Huntington’s disease (HD). The collaboration will use Singulex’s proprietary […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
